Emerging Role of CT and MR-Guided Online Adaptive Radiotherapy for Upper GI Malignancies
Online adaptive radiotherapy (ART) is a current and emerging technology and approach that leverages CT and MR images obtained on the treatment delivery platform to personalized daily RT fractions to account for organ and tumor motion, deformation, and positioning with the potential of improving o
Category
  • Adaptive RT
  • Gastrointestinal
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Implementation of a Prostate SBRT Program in the Community Setting
Conventionally fractionated external beam radiation therapy (EBRT) has a long-standing track record of safety and excellent treatment outcomes in the management of all prostate cancer risk groups.
Category
  • Genitourinary
  • SBRT
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Difficult Cases in Lung SBRT
This activity focuses on difficult cases in the use of lung SBRT. It includes a set of challenging cases followed by a short didactic session on each challenging topic. The cases/topics include: 1) SBRT for a large (>5 cm) primary, node negative tumor.
Category
  • SBRT
  • Thoracic
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Fine ART: Ever Evolving Online Adaptive Radiotherapy Technologies and Clinical Innovations
In the field of Adaptive Radiotherapy (ART), there are significant challenges in ensuring patient safety and treatment efficacy with the proper implementation of ART workflows and ART tools, effectively evaluating and implementing current clinical research, navigating the technical advancements a
Category
  • Adaptive RT
Format
  • Sessions onDemand
Credits
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Certificate of Attendance
Cost $149.00
Science Highlights 2024: Breast Cancer
This session highlights the most clinically relevant abstracts within the Breast Cancer track of the 2024 ASTRO Annual Meeting scientific program. These noteworthy scientific abstracts share important findings and feature cutting-edge research from leaders in the field.
Category
  • Central Nervous System
Format
  • Sessions onDemand
Credits
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Certificate of Attendance
Cost $79.00
Prevention and Management of Toxicity in Organs at Risk (OAR) in a Community Setting
This activity focuses entirely on issues related to the Organs at Risk (OAR) in the setting of thoracic radiation. Discussion centers on protecting the OARs and managing acute and late toxicities. Each speaker focuses on a different clinical situation.
Category
  • SBRT
  • Thoracic
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Radiopharmaceutical Therapy Workshop 2024
Radiopharmaceuticals are an increasingly utilized therapeutic option for the treatment of malignancies.
Category
  • Radiopharmaceutical Therapy
Format
  • Sessions onDemand
Credits
  • 4.50 AMA PRA Category 1 Credit™
  • 4.50 Certificate of Attendance
Cost $379.00
Integration of HPV ctDNA Testing into Clinical Practice for HPV+ OPSCC – Ready for Prime Time?
The use of HPV ctDNA in the clinical management of patients with HPV-associated oropharyngeal squamous cell carcinoma is rapidly increasing; however, questions remain regarding its utility and validity in various clinical settings.
Category
  • Head and Neck
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
A Case-Based Interactive Discussion of the ASTRO Clinical Practice Guideline for HPV-Positive Oropharyngeal Squamous Cell Carcinoma
This case-based activity is designed to provide learners with practical guidance on management of HPV-associated oropharyngeal squamous cell carcinoma (OPSCC) and highlight areas of uncertainty where there may be a range of acceptable treatment approaches.
Category
  • Head and Neck
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Multimodality Treatment De-Intensification in Low-Risk Breast Cancer: What Are the Limits?
This is a case-based panel activity, with a surgeon, a medical oncologist and a radiation oncologist. Each speaker reviews the current and ongoing studies addressing treatment de-intensification in their area of expertise.
Category
  • Breast
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00

Pages